Učitavanje...
Defining a New Role for the National Cancer Institute Cooperative Groups: More Science, Fewer Trials
In the context of major changes, it is likely that the National Cancer Institute’s Cooperative Groups will not have the resources to perform many of the traditional, definitive, randomized phase III trials of the past; industry will have to play a greater role in refining drug sequences or combinati...
Spremljeno u:
| Izdano u: | Oncologist |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AlphaMed Press
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221382/ https://ncbi.nlm.nih.gov/pubmed/25326160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0359 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|